Shorting Volatility is Bigger, and Riskier, Than Ever

NYSE: VXX | iPath Series B S&P 500 VIX Short-Term Futures ETN News, Ratings, and Charts

VXX – Selling option premium or shorting volatility has often been compared to picking up dimes in front of a steamroller.  Despite the risks and the not-too-distant blow-up of VIX- related products earlier this year, more money than ever is piling into these strategies. Read for details.

Selling option premium or shorting volatility has often been compared to picking up dimes in front of a steamroller.  Despite the risks and the not-too-distant blow-up of VIX- related products earlier this year, more money than ever is piling into these strategies.

And recent reports and data suggest that returns are shrinking, meaning people are now picking up pennies at the risk of being flattened by an adverse event.

The short volatility trade, where investors sell options to bet against equity price swings, is becoming less profitable. The strategy has, in theory, made no money for investors — 42% of the time since 2018, according to a report from IPS Strategic Capital, compared with a recent average of about 30% since 2012.

Funds that employ a covered call or put in writing that hope to track the Chicago Board of Options Exchange (CBOE)  ‘s  Buywrite , PutWrite and Iron Condor Indexes, which are all designed to  track the S&P 500, begun to badly lag over the past few years as option premium is not rich enough to compensate for the fact the strategies have capped or limited profit potential.

The concept behind these strategies is that income received from selling the options provides a cushion against drawdowns, while clipping some potential gains.

The lagging performance is attributable to the deteriorating spread between implied and realized equity index volatility, which is known as the volatility risk premium.

The market tendency is to price in a higher cushion for price swings compared with what comes to pass giving traders an opportunity to sell options and earn a premium along the way and keep the premium as implied volatility ultimately reverts or converges with realized volatility.

In addition, to the billions of dollars in mutual funds using the buy-write or put selling, there are also billions tied to VIX-related products and their options; these ‘derivatives of derivatives’ creates highly-leveraged positions in which losses can quickly multiple during an adverse move.

All of this comes even as economic uncertainty index has moved to its highest level in 5 years.

It seems that with lowered returns and higher risk, these strategies are running on borrowed time before a spike in volatility can create a loss in a few days that wipes out years of gains.


VXX shares were trading at $20.56 per share on Tuesday afternoon, down $0.12 (-0.58%). Year-to-date, VXX has declined -56.25%, versus a 21.93% rise in the benchmark S&P 500 index during the same period.


About the Author: Option Sensei


Steve has more than 30 years of investment experience with an expertise in options trading. He’s written for TheStreet.com, Minyanville and currently for Option Sensei. Learn more about Steve’s background, along with links to his most recent articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
VXXGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Stock Market Expert Predicts 3-6 Months of Pain

2 important market developments are leading market expert Steve Reitmeister to predict 3 to 6 months of painful market conditions pushing the S&P 500 (SPY) lower. Read on for the full story...

3 Pharmaceutical Stocks Addressing Global Health Challenges

With the recent rise of diseases, pharmaceutical companies are pushing boundaries in medicine, from life-saving treatments to pioneering global healthcare solutions. Hence, investing in established pharmaceutical stocks, Pfizer (PFE), Johnson & Johnson (JNJ), and Merck & Co. (MRK) presents a compelling opportunity to capitalize for the long term. Read more...

3 Tech Stocks Analysts Say Are "Strong Buys" for 2025

The technology industry is well-positioned for significant growth thanks to the rapid advancements in emerging technologies and the digitization of business operations. Amid this backdrop, fundamentally solid tech stocks Adobe (ADBE), Leidos Holdings (LDOS), and DocuSign (DOCU) could be strong buys for 2025. Continue reading...

3 Tech Stocks Under $20 With Breakout Potential

The tech sector is the core of innovation, from transforming industries to powering economic progress. Amid this backdrop, investors could consider buying sound under $20 tech stocks Vimeo (VMEO), PubMatic (PUBM), and Eventbrite (EB). Keep reading…

How Bad Will 2025 Be for Stocks?

As January goes...so goes the stock market. And right now that saying bodes poorly for the year ahead. Especially for the S&P 500 (SPY). That is why Steve Reitmeister shares 2 different paths the market could take in 2025 and how to get your portfolio on the right side of the action.

Read More Stories

More iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All VXX News